Videos
GS1 Standards – Clinical Trial
Published on
19 April 2024
- GS1 Standards were developed through collaboration among 60 representatives from 37 clinical trial organisations.
- Led by CEOs from Pfizer and Sanofi, the group worked with GS1 for nine months to create the GS1 application standard for identifying investigational products in clinical trials.
- The standard aims to streamline processes by focusing on identifying and barcoding investigational products, benefiting all parties involved.
- Benefits include faster progress, reduced errors, and easier adoption of data capture methods for clinical trial sites.
- Adopting the GS1 standard enhances trust throughout the supply chain, benefiting patients.